跳至主要内容
临床试验/NCT00263471
NCT00263471Unknown2 期

Phase 2 Study of the Effect of 7-Methylxanthine on the Progression of Childhood Myopia

Trier Research Laboratories0 个研究点目标入组 90 人开始时间: 2003年10月最近更新:
适应症
相关药物

试验速览

阶段
2 期
入组人数
90
主要终点
Axial growth

研究概览

简要总结

7-methylxanthine has been shown to increase the concentration and thickness of collagen fibrils in rabbit sclera. Deficient collagen in the sclera may be the cause of progression of childhood myopia. The study hypothesis is that treatment with 7-methylxanthine will stabilize the sclera and prevent further progression of myopia.

详细描述

Participants are given tablets of 7-methylxanthine 400 mg per day or placebo tablets for 12 months. Axial length, cycloplegic refraction and corneal curvature is measured, as well as weight, height, blood pressure and heart rate. The participants are interviewed about possible CNS, gastrointestinal, or cardiopulmonal side effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
8 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children in the age 8-13 years with myopia and an axial growth rate of 0.15 mm or more per year.

排除标准

  • Severe general ailment (for example diabetes, epilepsy, psychiatric disease) Eye diseases (for example cataract, keratoconus, chronic iritis, glaucoma)

结局指标

主要结局

Axial growth

次要结局

  • Myopia progression

研究者

申办方类型
Other

相似试验